Mesirow Financial Investment Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-485
Closed -$230K 541
2026
Q1
$230K Hold
485
﹤0.01% 473
2025
Q4
$227K Sell
485
-854
-64% -$396K ﹤0.01% 446
2025
Q3
$572K Buy
1,339
+19
+1% +$7.36K 0.01% 358
2025
Q2
$506K Buy
1,320
+328
+33% +$118K 0.01% 363
2025
Q1
$343K Sell
992
-758
-43% -$244K 0.01% 426
2024
Q4
$526K Buy
1,750
+988
+130% +$345K 0.01% 345
2024
Q3
$310K Buy
762
+112
+17% +$41K 0.01% 445
2024
Q2
$209K Buy
+650
New +$211K ﹤0.01% 468
2024
Q1
Sell
-810
Closed -$219K 563
2023
Q4
$219K Buy
+810
New +$200K 0.01% 505

Other funds holding HCA

Mesirow Financial Investment Management's HCA Position: Q2 2026 in Review

Mesirow Financial Investment Management sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 485 shares — an estimated $230K sold.

Mesirow Financial Investment Management first reported a position in HCA in Q4 2023 and held it in 9 quarters. The position peaked at $572K in Q3 2025. 1,331 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Mesirow Financial Investment Management reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 485 HCA Healthcare shares in Q2 2026, an estimated $230K.
  • Mesirow Financial Investment Management first reported a position in HCA Healthcare in Q4 2023 and held it in 9 quarters.
  • Mesirow Financial Investment Management's HCA Healthcare position peaked at $572K in Q3 2025.
  • 1,331 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.